(Total Views: 533)
Posted On: 06/11/2025 8:11:08 AM
Post# of 154596
hoops,
From your 6/10 post: "I think you have touched on a reason more PR's have not been issued... The new CRO is gleaning through the garbage data, looking for some nuggets of value to the FDA and medical community at large. Of course, the research team is conducting additional trials to enhance the pipeline."
So far in 2025, I don't think any humans have received Leronlimab as part of a new clinical trial.
Gentle edit: Of course, the research team will conduct additional trials ...
Non-gentle: Patience? No. Not when patients we can help move toward hospice care. The clock ticks. Arrgh.
From your 6/10 post: "I think you have touched on a reason more PR's have not been issued... The new CRO is gleaning through the garbage data, looking for some nuggets of value to the FDA and medical community at large. Of course, the research team is conducting additional trials to enhance the pipeline."
So far in 2025, I don't think any humans have received Leronlimab as part of a new clinical trial.
Gentle edit: Of course, the research team will conduct additional trials ...
Non-gentle: Patience? No. Not when patients we can help move toward hospice care. The clock ticks. Arrgh.
(9)
(0)
